Ladies and gentlemen, thank you for standing by, and welcome to the Tabula Rasa HealthCare, Inc. first-quarter 2020 earnings conference call. Certain statements made during this call will be forward-looking statements within the meaning of that law.
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 0.00% and 1.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Tabula Rasa HealthCare Corporation® (TRHC), a healthcare technology company advancing the field of medication safety, and Strategic Solutions Network, a privately-held business-to-business conference company, will present a free webinar entitled Important Medication Safety Considerations for COVID-19 Treatment on Thursday, May 7, 2020 at 1 p.m. EDT. The webinar will discuss the importance of understanding the risks associated with COVID-19 treatment risks, particularly with vulnerable individuals who have several chronic diseases and take multiple medications.
MOORESTOWN, N.J., May 11, 2020 -- Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces.
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
Tabula Rasa HealthCare®, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced an expanded laboratory services agreement with CQuentia, a comprehensive analytics platform and molecular laboratory for personalized medicine. The agreement provides TRHC with access to COVID-19 (SARS-CoV-2 RNA) testing kits for distribution to Programs of All-Inclusive Care for the Elderly (PACE) through TRHC’s CareKinesis Pharmacy. Through its relationship with CQuentia, TRHC also expects to have future access to new point-of-care, rapid testing technologies as well as to serological testing to determine whether a patient has COVID-19 antibodies.
MOORESTOWN, N.J., April 21, 2020 -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and.
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]
The research article is a 12-month analysis of medical claims data of 1,965 Program of All Inclusive Care for the Elderly (PACE ) participants by TRHC’s Precision Pharmacotherapy Research & Development Institute to determine their MedWise Risk Score™ (MRS). TRHC’s MedWise Risk Score™ helps identify those at highest risk for Adverse Drug Events (ADEs), requiring immediate medication management attention. Adverse Drug Events, if it were a disease, would be the third leading cause of death in the United States.
MOORESTOWN, N.J., May 04, 2020 -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today.
Tabula Rasa HealthCare® Corporation (TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19. “To address this need, our Precision Pharmacotherapy Research & Development Institute completed a systematic review of literature on the latest COVID-19 treatments and therapies and compiled them into a single source, eliminating the need for providers to access multiple sources to understand treatment options.”
MOORESTOWN, N.J., May 07, 2020 -- Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported.
CPSI vs. TRHC: Which Stock Is the Better Value Option?
Tabula Rasa Healthcare (TRHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HMSY vs. TRHC: Which Stock Is the Better Value Option?
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), which is in the healthcare services business, and is based in United...
Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tabula Rasa HealthCare Corporation® (TRHC), a healthcare technology company advancing the field of medication safety, announced today its running of a clinical study assessing the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19 in older adults on multiple medications. “This study showcases the depth and breadth of our clinical research capabilities,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “The results from the study will provide the framework for additional clinical trials that will continue to demonstrate the value of our risk stratification algorithms and processes.”
Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group
Tabula Rasa HealthCare, Inc. (TRHC), will release its first quarter 2020 operating results Thursday, May 7, 2020, after market close, on the investor relations section of TRHC’s website at ir.trhc.com. A conference call hosted by THRC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams will follow at 5:00 p.m. EDT. The conference call will be broadcast live in listen-only mode on the investor relations section of TRHC’s website (ir.trhc.com).